These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37085701)
1. A mathematical modeling technique to understand the role of decoy receptors in ligand-receptor interaction. Dey S; Ghosh A; Banerjee M Sci Rep; 2023 Apr; 13(1):6523. PubMed ID: 37085701 [TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Lin WW; Hsieh SL Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012 [TBL] [Abstract][Full Text] [Related]
3. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Roth W; Isenmann S; Nakamura M; Platten M; Wick W; Kleihues P; Bähr M; Ohgaki H; Ashkenazi A; Weller M Cancer Res; 2001 Mar; 61(6):2759-65. PubMed ID: 11289159 [TBL] [Abstract][Full Text] [Related]
4. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma. Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265 [TBL] [Abstract][Full Text] [Related]
5. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression. Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426 [TBL] [Abstract][Full Text] [Related]
6. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells. Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777 [TBL] [Abstract][Full Text] [Related]
7. Serum concentration of soluble decoy receptor 3 in glioma patients before and after surgery. Hwang SL; Lin CL; Cheng CY; Lin FA; Lieu AS; Howng SL; Lee KS Kaohsiung J Med Sci; 2004 Mar; 20(3):124-7. PubMed ID: 15124896 [TBL] [Abstract][Full Text] [Related]
8. Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling. Weng SC; Wen MC; Hsieh SL; Chen NJ; Tarng DC Front Immunol; 2022; 13():879648. PubMed ID: 35720343 [TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions. Hsieh SL; Lin WW J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361 [TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts. Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3). You RI; Chang YC; Chen PM; Wang WS; Hsu TL; Yang CY; Lee CT; Hsieh SL Blood; 2008 Feb; 111(3):1480-8. PubMed ID: 18006694 [TBL] [Abstract][Full Text] [Related]
12. Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB. Huang ZM; Kang JK; Chen CY; Tseng TH; Chang CW; Chang YC; Tai SK; Hsieh SL; Leu CM J Immunol; 2012 Jun; 188(12):5867-76. PubMed ID: 22581854 [TBL] [Abstract][Full Text] [Related]
13. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1. Xu YC; Cui J; Zhang LJ; Zhang DX; Xing BC; Huang XW; Wu JX; Liang CJ; Li GM Chin Med J (Engl); 2018 Jan; 131(1):82-87. PubMed ID: 29271385 [TBL] [Abstract][Full Text] [Related]
14. Functional characterisation of decoy receptor 3 in Crohn's disease. Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2. Zhou XN; Li GM; Xu YC; Zhao TJ; Wu JX Chin Med J (Engl); 2016 Nov; 129(21):2623-2629. PubMed ID: 27779171 [TBL] [Abstract][Full Text] [Related]